Results 31 to 40 of about 52,343 (282)

The basic principals of pharmacogenetics testing in cancer treatment [PDF]

open access: yesHospital Pharmacology, 2020
Introduction: Precision medicine is an approach that considers genetics, environment and lifestyle factors when prevent and treat different diseases. The important part of precision medicine is pharmacogenetics, a branch of clinical pharmacology that ...
Cikota-Aleksić Bojana M.   +3 more
doaj  

Pharmacogenetics of asthma [PDF]

open access: yesEuropean Respiratory Journal, 2000
Pharmacogenetics offers the potential to optimize treatment for individual patients by using genetic information to improve efficacy or avoid side effects. While there are a number of examples in which the approach is already in routine clinical usage, exploitation of this approach in asthma is still under development.
openaire   +5 more sources

Pharmacogenetics in Clinical Practice

open access: yesPrague Medical Report, 2012
Pharmacogenetics is a discipline that investigates how genetic variation relates to the drug efficacy and safety. The goal of pharmacogenetics is a personalized treatment, where according to genotype we would be able to prescribe the most effective drug ...
Hana Bakhouche, O. Slanař
doaj   +1 more source

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later

open access: yesClinical pharmacology and therapy, 2019
In 2009, the Clinical Pharmacogenetics Implementation Consortium (CPIC, www.cpicpgx.org), a shared project between Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) and the National Institutes of Health (NIH), was created to provide ...
M. Relling   +5 more
semanticscholar   +1 more source

The role of pharmacogenetics in keloid scar treatment: A literature review

open access: yesScars, Burns & Healing, 2020
Background: The pathophysiology of keloid scars is still not fully understood and a universally reliable effective treatment has not been identified. Pharmacogenetics explores how drug response to a particular therapy can relate to genetic variations ...
Tamara Searle   +2 more
doaj   +1 more source

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes. [PDF]

open access: yesAnn Hum Genet
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
McDermott JH   +3 more
europepmc   +2 more sources

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines

open access: yesEuropean Journal of Human Genetics, 2019
Despite advances in the field of pharmacogenetics (PGx), clinical acceptance has remained limited. The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize ...
C. Lunenburg   +14 more
semanticscholar   +1 more source

Integrating rare genetic variants into pharmacogenetic drug response predictions

open access: yesHuman Genomics, 2018
Background Variability in genes implicated in drug pharmacokinetics or drug response can modulate treatment efficacy or predispose to adverse drug reactions.
Magnus Ingelman-Sundberg   +3 more
doaj   +1 more source

Pharmacogenetics of thiopurines

open access: yesCancer Drug Resistance, 2019
Polychemotherapeutic protocols for the treatment of pediatric acute lymphoblastic leukemia (ALL) always include thiopurines. Specific approaches vary in terms of drugs, dosages and combinations. Such therapeutic schemes, including risk-adapted intensity, have been extremely successful for children with ALL who have reached an outstanding 5-year ...
Raffaella Franca   +6 more
openaire   +4 more sources

Systematic identification of non-coding pharmacogenomic landscape in cancer

open access: yesNature Communications, 2018
In this study the authors build lncRNA-drug response models for 265 anti-cancer agents across 27 cancer types. They report their cancer cell line based lncRNA EN-models are able to effectively predict therapeutic outcome for breast cancer, ovarian cancer,
Yue Wang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy